ScholarIQanswers from OpenAlex

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis

PaperCitations, authors & open-access status

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis have?

ScholarIQcitation count

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis has 230 citations in the OpenAlex counts ScholarIQ stores.

When was Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis published?

ScholarIQyear

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis has 2018 year in the ScholarIQ index.

What is the open-access status of Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis?

ScholarIQoa status

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis has closed oa status in the ScholarIQ index.

What is the DOI of Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis?

ScholarIQdoi

The DOI for Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis is on the source record.

What is the PMID of Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis?

ScholarIQpmid

The PMID for Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis is on the source record.

What is the OpenAlex record for Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis?

ScholarIQopenalex

The OpenAlex for Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial